PLEASANTON, Calif., Nov. 20, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2025. "Continuing to lead through innovation, Veeva AI delivers on our vision for industry-specific AI that will help the life sciences industry reach new levels of productivity and customer centricity," said CEO Peter Gassner. "Veeva AI is advancing rapidly and our early ado ...

Fears of a growing bubble around the artificial intelligence frenzy resurfaced on Thursday as leading US stock markets fell, less than 24 hours after strong results from chipmaker Nvidia sparked a rally.Wall Street initially rose after Nvidia, the world’s largest public company, reassured investors of strong demand for its advanced data center chips. But the relief dissipated, and technology stocks at the heart of the AI boom came under pressure.The benchmark S&P 500 closed down 1.6%, and the Dow Jones indu ...

Oracle Corp., the once stodgy database giant that’s borrowed tens of billions and tethered its fortunes to the artificial intelligence boom, is quickly emerging as the credit market’s barometer for AI risk.Traders have piled into the company’s credit-default swaps in recent months as Oracle’s massive AI-related spending spree, its central role in a web of interrelated deals, and its weaker credit grades compared with players such as Microsoft Corp. or Alphabet Inc. have made the contracts the market’s prefe ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Intuit forecast second-quarter revenue growth above Wall Street estimates on Thursday, a sign of growing demand for its artificial intelligence-powered financial management tools. ...

Question-and-Answer SessionWe really appreciate it. So Natera is a leading diagnostic company focused on leveraging cell-free DNA technology across prenatal testing. And more in focus these days is the market leader, a pioneer in really advancing the field of minimal residual disease testing or MRD. So again, thanks for being here, Mike.Douglas SchenkelWolfe Research, LLC Lots to cover. I know we won't get through all of it. And between the 2 of us, we have a hard time doing that. But I think it's a good pr ...

SAN JOSE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 37th Annual Piper Sandler Healthcare Conference in New York City. Management is scheduled to present on Tuesday, December 2 at 8:30 a.m. Eastern Time. A live webcast of each event, as well as an archived recording, will be ...

Question-and-Answer SessionSo before we kick it off, why don't you make some opening remarks in terms of just the progress over the last several years and importantly, what has happened this year, some of the accomplishments? And then how you're thinking about 2026?Benjamin HalladayChief Financial Officer Yes. There's a lot to unpack with that question. I'll do my best to keep it minimal. So I'll go back to April of 2024 when we received our cardiovascular outcomes trial updated label, which really kind of ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Viewpoint - RBC Capital has adjusted its rating for Target Corporation to "Outperform" while lowering its price target from $107 to $99 amid significant challenges faced by the company, including disappointing third-quarter performance and a revised full-year earnings forecast [1][6]. Financial Performance - Target's comparable sales have contracted more than expected, leading to profitability issues and a revised full-year earnings per share (EPS) outlook of $7 to $8, influenced by a cooling job market and inflation [2][6]. - The stock has declined nearly 35% this year, contrasting with the S&P 500's 13% rise, indicating significant underperformance relative to the broader market [3][6]. Strategic Initiatives - Despite current challenges, Target is investing in technology, including AI-enabled consumer insights and the Target Trend Brain, to enhance merchandising and predict consumer trends [4][6]. - The company has experienced a 35% growth in digital sales, particularly in same-day delivery services, and has improved inventory management with a 150-basis-point improvement in on-shelf availability for top items [4]. Expansion and Investment - Target is expanding its store footprint with new larger format stores that are exceeding sales expectations, and is investing in store remodels and digital tools to enhance the guest shopping experience [5][6]. - As of now, Target's stock is priced at approximately $86.37, with a market capitalization of around $39.25 billion and a trading volume of 2,993,855 shares [5].